Atlas Trials

Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia

Clinical trial NCT02533232 · UNKNOWN

Trial details

NCT number
NCT02533232
Sponsor
Pakistan Institute of Living and Learning
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Start date
2022-08-30
Primary completion
2022-12-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.